Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

NCT04121442 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

BIOLOGICAL: Isunakinra
BIOLOGICAL: PD-(L)1 Inhibitor

Sponsor

Buzzard Pharmaceuticals

Collaborators

[object Object]